Concentric
VC Fund
London, United Kingdom
Concentric is a VC fund in London focused on Financial Services and Software. Concentric invests in software technology business in the financial services, mobility, real estate, industrial, and logistics sectors.
- Total investments:
- 98
- Last investment:
- Lead investor:
- 34%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Concentric invests in
Stages Concentric invests in
Countries Concentric invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Round size
- Seed
- $878k–$5.8M
- Series A
- $1.8M–$25M
- Series B
- $1.7M–$225M
Investment Focus
Industry
- Financial Services 15 (15%)
- Software 12 (12%)
- Bitcoin 9 (9%)
- Cryptocurrency 7 (7%)
- FinTech 6 (6%)
Stage
- Seed 31 (32%)
- Series A 18 (18%)
- Series B 11 (11%)
- Funding Round 5 (5%)
- Pre-Seed 4 (4%)
Country
- United Kingdom 22 (22%)
- United States 9 (9%)
- Germany 3 (3%)
- Switzerland 3 (3%)
- Brazil 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Kjartan Rist
Founding Partner
|
Founding Partner | Total investments: 15 | Find email | |
Alexander Mann
Principal
|
Principal | Total investments: 28 | Find email | |
Alexander Stroud
Principal
|
Principal | Total investments: 6 | Find email | |
Denis Shafranik
Partner & Co-Founder
|
Partner & Co-Founder | Total investments: 33 | Find email | |
Ilya Belyaev
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Preventive healthcare platform that equips people with personalized insights and expert guidance for proactive whole-body health | $3.8M / Seed / Sep 14, 2026 | ||
| Pockit is a fintech business that focuses on providing financial services primarily to customers who are typically excluded or at least underserved by high street banks. It provides a digital banking app designed to cater to the underbanked masses. | $17.9M / Venture - Series Unknown / Jun 08, 2026 | ||
| Paypercut is a fintech startup that allows small and mid-scaled merchants to offer Buy Now, Pay Later at checkout via a single integration. | $5.8M / Seed / Jun 03, 2026 | ||
| Visium is a consulting company specialized in artificial intelligence, machine learning, and consulting. It delivers value to companies at every level of AI development, whether they are just entering the field or have a solid data science department. The company was founded in 2018 and headquartered in Zurich, Switzerland. | May 20, 2026 | ||
| Paypercut is a fintech startup that allows small and mid-scaled merchants to offer Buy Now, Pay Later at checkout via a single integration. | $2.3M / Pre-Seed / Jul 16, 2025 | ||
| Preventive healthcare platform that equips people with personalized insights and expert guidance for proactive whole-body health | $9.4M / Seed / Jun 04, 2025 | ||
| LN Markets offers bitcoin derivatives trading exchange platform. | $3M / Series A / Feb 02, 2025 | ||
| Breez provides a simple, fast and safe way to spend your bitcoins. Powered by Lightning Network, Breez is the future of commerce. | $4.5M / Series A / Jan 19, 2025 | ||
| Bipa is a Brazilian fintech and digital account built around Bitcoin and USDT. Founded in 2020, Bipa connects the traditional financial system to digital assets — allowing users to buy and sell crypto starting from R$1 via Pix, pay any bill using Bitcoin, earn Bitcoin cashback (Satsback®) on every card purchase, and self-custody their funds viaLightning Network and on-chain withdrawals. | $2.8M / Seed / Dec 05, 2024 | ||
| Transcend Therapeutics is a clinical-stage biotechnology company focused on developing rapid-acting treatments for neuropsychiatric diseases. The company aims to address mental health conditions such as post-traumatic stress disorder (PTSD) and major depressive disorder (MDD), particularly for patients who do not respond to existing therapies. Thecompany’s lead program, TSND-201 (methylone), is being developed as a next-generation neuroplastogen designed to deliver fast and durable therapeutic effects. Its research emphasizes innovative psychoactive compounds that can improve outcomes while minimizing common limitations of traditional psychiatric medications. Backed by venture funding and an experienced leadership team with multiple FDA approvals, Transcend Therapeutics continues to advance clinical trials and expand its pipeline of mental health treatments. | Convertible Note / Oct 28, 2024 | ||
| See all 98 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Concentric invest in?
Concentric invests primarily in Financial Services, Software and Bitcoin startups, most often at Seed and Series A stage. Most of the 98 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Concentric's check size?
Concentric typically joins rounds of $878k–$5.8M at Seed, $1.8M–$25M at Series A and $1.7M–$225M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Concentric participates in.
How do I contact Concentric?
Public channels for Concentric include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Concentric?
The team at Concentric includes Kjartan Rist (Founding Partner), Alexander Mann (Principal) and Alexander Stroud (Principal), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
